← Back to Search

YORS for Opioid Use Disorder (YORS Trial)

N/A
Recruiting
Led By Marc Fishman, MD
Research Sponsored by Potomac Health Foundations
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time frame: data measured every 2 weeks for the duration of the 26-week study period
Awards & highlights

YORS Trial Summary

This trial seeks to find a more effective way to help young adults with opioid use disorder stay on their medication and in treatment, in order to improve public health outcomes related to the opioid crisis.

Who is the study for?
This trial is for young adults aged 18-28 with opioid use disorder who are willing to take relapse prevention medications and involve a family member or significant other in their treatment. It's not suitable for those living too far from the center, experiencing homelessness, or dealing with severe psychiatric or medical conditions.Check my eligibility
What is being tested?
The YORS intervention is being tested to see if it helps young adults stick to their medication plans and stay engaged in treatment. The study includes refining the program through feedback and then testing its effectiveness compared to standard care.See study design
What are the potential side effects?
Since this trial focuses on support interventions rather than medications, specific side effects aren't listed. However, participants may experience emotional or psychological impacts related to therapy sessions.

YORS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time frame: data measured every 2 weeks for the duration of the 26-week study period
This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame: data measured every 2 weeks for the duration of the 26-week study period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of MOUD injections received (XR-NTX or XR-BUP)
Rate of opioid relapse during the study period

YORS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Youth Opioid Recovery Support (YORS)Experimental Treatment1 Intervention
The Youth Opioid Recovery Support (YORS) model is an innovative wrap-around approach that attempts to address barriers to treatment engagement in this vulnerable young adult population, especially difficulties with medication adherence. Its components include: (1) Home delivery of extended release naltrexone (XR-NTX) for OUD; (2) Engagement of families in collaborative treatment planning and monitoring focusing on medication adherence; (3) Assertive outreach from the treatment team including actively tracking and communicating with youth and families by text messaging and social media to promote engagement and adherence; and (4) Contingency management to provide incentives for medication adherence. The specific components of YORS will be refined and adapted based on feedback from interviews and focus groups with various stakeholders. However, the basic framework outlined above is expected to persists.
Group II: Treatment As UsualActive Control1 Intervention
TAU will contain patients who will be receiving treatment for opioid use disorder through their usual venues without the family engagement, assertive outreach, contingency management, and home delivery of medication. This often includes a referral and warm hand off to intensive outpatient SUD services and/or mental health care.

Find a Location

Who is running the clinical trial?

Friends Research Institute, Inc.OTHER
53 Previous Clinical Trials
20,653 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,485 Previous Clinical Trials
2,622,230 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
837 Previous Clinical Trials
669,593 Total Patients Enrolled

Media Library

Youth Opioid Recovery Support (YORS) Clinical Trial Eligibility Overview. Trial Name: NCT04173416 — N/A
Opioid Use Disorder Research Study Groups: Youth Opioid Recovery Support (YORS), Treatment As Usual
Opioid Use Disorder Clinical Trial 2023: Youth Opioid Recovery Support (YORS) Highlights & Side Effects. Trial Name: NCT04173416 — N/A
Youth Opioid Recovery Support (YORS) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04173416 — N/A
~8 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top